^“Effect of the selective 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 on 5-HTP-induced head shaking and behavioral symptoms induced by 5-methoxy-N,N,dimethyltryptamine in rats: comparison with some other 5-HT receptor antagonists”. Psychopharmacology92 (4): 520-3. (1987). doi:10.1007/bf00176488. PMID3114804.
^“Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen”. Am. J. Clin. Oncol.16 (2): 175-9. (April 1993). doi:10.1097/00000421-199304000-00020. PMID8452114.
^“Effects of MDL 72222, a serotonin3 antagonist, on operant responding for ethanol by alcohol-preferring P rats”. Alcohol. Clin. Exp. Res.24 (10): 1500-4. (October 2000). doi:10.1111/j.1530-0277.2000.tb04567.x. PMID11045857.
^“5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat”. Psychopharmacology159 (4): 341-50. (February 2002). doi:10.1007/s00213-001-0939-4. PMID11823886.
^“Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice”. Eur Neuropsychopharmacol16 (4): 297-310. (May 2006). doi:10.1016/j.euroneuro.2005.10.001. PMID16288851.
^“Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice”. Synapse62 (1): 8-13. (January 2008). doi:10.1002/syn.20461. PMID17948891.